Rare botulism cases reviewed to improve ICU care
NCT ID NCT03658902
First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This study reviews the medical records of people who were hospitalized in French intensive care units (ICUs) for severe botulism poisoning. Botulism is a rare but serious illness caused by a toxin that can paralyze muscles. The goal is to describe what happened to these patients, what treatments they received, and how they fared, in order to give doctors a clearer picture of modern botulism care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better understand and treat severe botulism, potentially improving survival and care in intensive care units.
- What could go wrong
- This is a small, retrospective study that only looks at past records, so it cannot prove what treatments work best. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BOTULISM; POISONING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier Le Mans
Le Mans, 72000, France